Cerebral small vessel disease genomics and its implications across the lifespan
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- PersonId : 174786
- IdHAL : laurent-petit
- ORCID : 0000-0003-2499-5367
- IdRef : 087584751
- Function : Author
- PersonId : 801914
- ORCID : 0000-0001-5160-6203
- Function : Author
- PersonId : 738912
- IdHAL : laure-zago
- ORCID : 0000-0001-8235-2154
- IdRef : 171658795
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- PersonId : 1601252
- ORCID : 0000-0003-3367-1778
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- PersonId : 756626
- ORCID : 0000-0001-9088-234X
- IdRef : 058556818
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- PersonId : 794248
- ORCID : 0000-0002-8843-406X
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- PersonId : 1322158
- IdHAL : david-tregouet
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- PersonId : 757140
- ORCID : 0000-0003-0970-2837
- IdRef : 059391170
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- Function : Author
- PersonId : 1050442
Abstract
Cerebral small vessel disease genomics and its implications across the lifespan Muralidharan Sargurupremraj et al. # White matter hyperintensities (WMH) are the most common brain-imaging feature of cerebral small vessel disease (SVD), hypertension being the main known risk factor. Here, we identify 27 genome-wide loci for WMH-volume in a cohort of 50,970 older individuals, accounting for modification/confounding by hypertension. Aggregated WMH risk variants were associated with altered white matter integrity (p = 2.5×10-7) in brain images from 1,738 young healthy adults, providing insight into the lifetime impact of SVD genetic risk. Mendelian randomization suggested causal association of increasing WMH-volume with stroke, Alzheimer-type dementia, and of increasing blood pressure (BP) with larger WMH-volume, notably also in persons without clinical hypertension. Transcriptome-wide colocalization analyses showed association of WMH-volume with expression of 39 genes, of which four encode known drug targets. Finally, we provide insight into BP-independent biological pathways underlying SVD and suggest potential for genetic stratification of high-risk individuals and for genetically-informed prioritization of drug targets for prevention trials.
Domains
| Origin | Publication funded by an institution |
|---|---|
| Licence |